CD1D and neoplasm: NKT cells, a subset of CD1d-restricted T cells, have also been proved as a promising boon in manifestation of cancer immunotherapy through a variety of mechanisms, including killing tumor cells directly, influencing immunosuppressive cells in the TME, secretion of cytokines, and stimulating tumor-specific T cells and NK cells which leads to elimination of tumor cells [91, 92].